Description: SBI Holdings, Inc. engages in the online financial service businesses and investment activities in Japan and internationally. It operates through Financial Services Business, Asset Management Business, and Biotechnology-Related Business segments. The Financial Services Business segment offers financial products and services, including brokerage and investment banking; Internet banking; auto, cancer, fire, and earthquake, as well as life insurance; short term insurance; FX brokerage; exchange and transaction services related to crypto-assets; management of defined-contribution pension, etc.; leasing and lending services; operation of proprietary trading system; control and operation of the e-commerce settlement business; and remittance and back office support services. The Asset Management Business segment provides private equity, venture capital fund management, M&A advisory, savings bank, online securities, commercial banking, investment advisory and management, fintech support, and rating information services; real estate secured loans; and rent guarantees for rental housing, as well as generates power using renewable energy. The Biotechnology-Related Business segment develops and distributes pharmaceutical products, health foods, and cosmetics; and researches and develops antibody drugs and nucleic acid medicines in the field of cancer and immunology. The company also offers investment advisory services on crypto-asset funds; operates a fund-raising platform; acquires securities; operates as a crypto-asset broker; develops, manufactures, and sells crypto-asset mining systems; operates and develops cybersecurity systems; provides blockchain platform; invests in real estate properties; and offers healthcare services, as well as engages in the mining of digital assets. The company was formerly known as Softbank Investment Corporation and changed its name to SBI Holdings, Inc. in July 2005. SBI Holdings, Inc. was founded in 1999 and is headquartered in Tokyo, Japan.
Home Page: www.sbigroup.co.jp
Izumi Garden Tower
Tokyo,
106-6019
Japan
Phone:
81 3 6229 0100
Officers
Name | Title |
---|---|
Mr. Yoshitaka Kitao | Chairman, Pres & CEO |
Mr. Masato Takamura | Sr. EVP, COO, Sr. Head of Financial Services Bus. & Representative Director |
Mr. Takashi Nakagawa | Sr. EVP, Sr. Head of HR, Gen. Affairs & Risk Mgt and Representative Director |
Mr. Tomoya Asakura | Sr. Exec. VP & Director |
Mr. Hideyuki Katsuchi | CFO & Managing Exec. Officer |
Mr. Shumpei Morita | Sr. MD, SEVP, Sr. Head of Accounting, Fin. & Digital Asset Bus. and Director |
Mr. Masayuki Yamada | Gen. Counsel of Legal & Compliance Dept. and Director |
Ms. Ayumi Takeuchi | GM of Corp. Communication Department & Exec. Officer |
Ms. Satoe Kusakabe | MD & Director |
Ms. Wai Han Leung ACIS, ACS | Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 2.4382 |
Price-to-Book MRQ: | 0.729 |
Price-to-Sales TTM: | 0.0059 |
IPO Date: | |
Fiscal Year End: | March |
Full Time Employees: | 17496 |